Venrock Healthcare Capital Partners III L.P. 13D and 13G filings for Century Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-02-14 6:14 pm Sale |
2024-12-31 | 13G | Century Therapeutics, Inc. IPSC |
Venrock Healthcare Capital Partners III L.P. | 3,957,186 4.700% |
-1,432,073 (-26.57%) |
Filing |
| 2024-11-14 5:46 pm Purchase |
2024-09-30 | 13G | Century Therapeutics, Inc. IPSC |
Venrock Healthcare Capital Partners III L.P. | 5,389,259 6.400% |
1,984,126 (+58.27%) |
Filing |
| 2024-03-04 4:16 pm Purchase |
2024-02-21 | 13G | Century Therapeutics, Inc. IPSC |
Venrock Healthcare Capital Partners III L.P. | 3,405,133 5.400% |
3,405,133 (New Position) |
Filing |